Status:

RECRUITING

Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

San Francisco Tech Council

National Institute on Minority Health and Health Disparities (NIMHD)

Conditions:

Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study examines the impact of a multi-level intervention aiming to improve telehealth access for low-income patients managing chronic health conditions, such as hypertension and diabetes. The mult...

Detailed Description

ACCTIVATE is a multi-level intervention (including practice facilitation and patient digital coaching) that aims to tackle patient-level and clinic-level barriers to increase the equitable use of tele...

Eligibility Criteria

Inclusion

  • ≥ 18 years of age
  • English or Spanish-Speaking
  • Have uncontrolled diabetes defined as a listed diagnosis of diabetes with a recorded A1C ≥ 8.0% in the past two years or have uncontrolled HTN defined as a listed diagnosis of HTN and last recorded documented SBP \>140 mmHg
  • At least 2 visits at a participating SFHN primary care site in the last 24 months

Exclusion

  • Higher than average digital literacy, defined as an Digital Healthcare Literacy Scale (DHLS) score greater than 10, as determined prior to the baseline study visit; these patients may not benefit from a digital coaching intervention.
  • Presence of co-morbid conditions that would make it inappropriate to focus on telehealth chronic disease management. Conditions may include: end-stage or terminal condition with limited life expectancy and severe mental illness.
  • Lack of any working phone number
  • Visual or hearing impairment that precludes use of telehealth for chronic disease management
  • Cognitive impairment defined by the inability to restate study goals during the consent process
  • Pregnant

Key Trial Info

Start Date :

November 4 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2028

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT06598436

Start Date

November 4 2024

End Date

September 1 2028

Last Update

January 6 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zuckerberg San Francisco General Hospital (ZSFG) & SF Department of Public Health (DPH)

San Francisco, California, United States, 94110